Northwire Canada EditionMonday, July 13, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Aurora Cannabis wins EU rights for two cannabis strains

By The Northwire Desk — AI Analysis Jan 20, 2026 · 16:06 ACB · 5.82 Aurora Cannabis Inc
ACB · Price

Executive Summary

  • Aurora Cannabis Inc. has been granted EU Community Plant Variety Rights for two proprietary cannabis strains, Farm Gas and Sourdough, securing exclusive commercial production and sales rights across all 27 EU member states.
  • The intellectual property grant strengthens Aurora's global genetics portfolio, protects R&D investments, and enhances its competitive positioning in the high-value European medical cannabis market.
  • Both cultivars are already established core medical products in Germany, Poland, the UK, Canada, and Australia, recognized for high potency, consistent performance, and desirable consumer traits.

Key Details

  • Granted Rights: EU Community Plant Variety Rights issued by the Community Plant Variety Office.
  • Protected Varieties: Cannabis sativa L. SOT20R07-007 (commercially known as Farm Gas) and ACB21T044 (commercially known as Sourdough).
  • Geographic Scope: Exclusive control over commercial production and sale throughout all 27 European Union member states for the full duration of the protection period.
  • Breeding & R&D: Developed in Canada through Aurora's advanced breeding and phenotyping programs at the Aurora Coast R&D facility.
  • Product Traits: High potency, desirable aromas, strong bud structure, consistency, and strong performance traits.
  • Current Market Presence: Core products for medical patients in Germany, Poland, the United Kingdom, Canada, and Australia.
  • Production & Distribution: Cultivated across Aurora's proprietary network of cultivation sites, as well as by external partners and licensees globally.
  • Strategic Impact: Enhances Aurora's global genetics platform, supports premium product delivery, and solidifies its competitive advantage in the fast-moving European market.

Notable Quotes

  • Lana Culley, Vice-President of Innovation and International Operations: "Being granted Community Plant Variety rights in the EU is a direct recognition of the exceptional cannabis genetics work under way at our preeminent Aurora Coast R&D facility that is unmatched in its level of excellence... This protection not only strengthens Aurora's global genetics portfolio, but also ensures that our high-quality, differentiated varieties can consistently reach patients and consumers worldwide. Aurora remains committed to advancing our unique breeding program and developing genetics that set new standards in cannabis cultivation."
Read the original news release →

More from Aurora Cannabis Inc

Jun 11, 2026 · 07:05

Record FY2026 revenue masks structural margin contraction and explicit FY2027 guide-cut; cash-rich but capital allocation remains dilutive.

Earnings May 14, 2026 · 08:45

Aurora Cannabis Secures IP Rights Amidst Sector Consolidation and Price Stabilization

M&A / Property May 14, 2026 · 06:54

Aurora Secures IP Moat Amidst Dilution Concerns and Cash Burn

M&A / Property Apr 28, 2026 · 15:57

Aurora Cannabis Expands Global Medical Portfolio Amidst Dilution Concerns and Profitability Push

Production / Operations Apr 28, 2026 · 06:53

Product Expansion Validates EU Capacity Play, But Dilution Risk Looms Over Cash Burn

Production / Operations Apr 15, 2026 · 07:05

Aurora Cannabis Acquires EU GMP Capacity Amidst Stock Decline

M&A / Property